| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Toula Kourgiantakis, Eunjung Lee, A Kumsal Tekirdag Kosar, Christine Tait, Carrie K Y Lau, Sandra McNeil, Shelley Craig, Rachelle Ashcroft, Charmaine C Williams, Abby L Goldstein, Uppala Chandrasekera, Deepy Sur, J L Henderso. Youth cannabis use in Canada post-legalization: service providers' perceptions, practices, and recommendations. Substance abuse treatment, prevention, and policy. vol 18. issue 1. 2023-06-22. PMID:37349741. |
youth cannabis use is associated with various adverse effects including psychosis, anxiety, depression, suicidality, respiratory distress, cannabinoid hyperemesis syndrome, and intoxications. |
2023-06-22 |
2023-08-14 |
Not clear |
| Hassaan Iftikhar, Maryam Saleem, Hafiz S Naeem, Dania Fatim. Synthetic Cannabinoids and ST-Elevated Myocardial Infarction: A Case Report and Literature Review. Cureus. vol 15. issue 5. 2023-06-20. PMID:37337483. |
the use of synthetic cannabinoids and marijuana has been known to be associated with myocardial infarction and coronary vasospasms according to a few case reports published for the pediatric population. |
2023-06-20 |
2023-08-14 |
Not clear |
| Graham Grogan, Kristen Stephens, Jesse Chou, Michael P Timko, Patrick Cottler, Brent R DeGeorg. The Mechanism of Cannabichromene and Cannabidiol Alone Versus in Combination in the Alleviation of Arthritis-Related Inflammation. Annals of plastic surgery. vol 90. issue 6S Suppl 4. 2023-06-19. PMID:37332213. |
cannabidiol (cbd) and cannabichromene (cbc) are minor cannabinoids with reported analgesic and anti-inflammatory properties and have been implicated as potential therapeutics for arthritis-related pain. |
2023-06-19 |
2023-08-14 |
Not clear |
| Heather Barkholtz, Maia Bate. Measuring the diversity gap of cannabis clinical trial participants compared to people who report using cannabis. Scientific reports. vol 13. issue 1. 2023-06-16. PMID:37328519. |
to understand if these population subgroups are represented in cannabis clinical trials, participant demographics were extracted from peer-reviewed clinical trials reporting on pharmacokinetic and/or pharmacodynamic models of cannabis or cannabinoids. |
2023-06-16 |
2023-08-14 |
human |
| Carole M Lindsay, Khalia K Bernard, Amanda M Hammond, Sheldon Beckford, Wendel D Abel, Paul D Brown, Lauriann E Youn. Potency trends of cannabis in Jamaica during the period of 2014 to 2020. Drug testing and analysis. 2023-06-13. PMID:37309060. |
cannabinoids are the terpeno-phenolic compounds found in the cannabis plant and are responsible for its pharmacological activity. |
2023-06-13 |
2023-08-14 |
Not clear |
| Santiago Gómez Velásquez, Ángela María Amaya Heredia, Santiago Bedoya Moncada, Juan Esteban Patiño González, Jorge Ariel Martínez Ramíre. [Recreational cannabis: Profile of cannabinoids present in marijuana samples supplied by the consuming population]. Salud colectiva. vol 19. 2023-06-13. PMID:37311141. |
[recreational cannabis: profile of cannabinoids present in marijuana samples supplied by the consuming population]. |
2023-06-13 |
2023-08-14 |
Not clear |
| Santiago Gómez Velásquez, Ángela María Amaya Heredia, Santiago Bedoya Moncada, Juan Esteban Patiño González, Jorge Ariel Martínez Ramíre. [Recreational cannabis: Profile of cannabinoids present in marijuana samples supplied by the consuming population]. Salud colectiva. vol 19. 2023-06-13. PMID:37311141. |
tetrahydrocannabinol (thc) was found to be the main constituent of circulating marijuana in medellín, where 67.8% of the samples had a high or higher toxicological range for thc; the foregoing in a context where the deregulated market in practice limits the possibility that consumers have to calibrate or decide the concentration of cannabinoids in their doses. |
2023-06-13 |
2023-08-14 |
Not clear |
| Emily Geraci, Carrie Cake, Kevin M Mulieri, Norman E Fen. Comparison of Antiemetics in the Management of Pediatric Cannabinoid Hyperemesis Syndrome. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. vol 28. issue 3. 2023-06-12. PMID:37303765. |
as a result of recent legislative changes allowing for increased access to marijuana products, there have been increasing rates of cannabis abuse among adolescents and subsequent diagnoses of cannabinoid hyperemesis syndrome (chs). |
2023-06-12 |
2023-08-14 |
Not clear |
| María Del Mar Cajiao-Manrique, Verònica Casadó-Anguera, Alejandra García-Blanco, Rafael Maldonado, Elena Martín-Garcí. THC exposure during adolescence increases impulsivity-like behavior in adulthood in a WIN 55,212-2 self-administration mouse model. Frontiers in psychiatry. vol 14. 2023-06-12. PMID:37304451. |
regular cannabis consumption typically begins during adolescence, and this early cannabinoid exposure may increase the risk for drug addiction in adulthood. |
2023-06-12 |
2023-08-14 |
mouse |
| Vishweshwara Bhat, Emmanuel Shan Onaivi, Venkatanarayanan Sharm. Endocannabinoid system components as potential neuroimmune therapeutic targets in tinnitus. Frontiers in neurology. vol 14. 2023-06-12. PMID:37305742. |
with the current and increasing global medical and recreational cannabis legalization, there is renewed enthusiasm for the use of cannabinoid drugs, and the role of the endocannabinoid system (ecs) in several health disorders including tinnitus which is associated with covid-19. |
2023-06-12 |
2023-08-14 |
Not clear |
| Luigi Bellocchio, Assunta Patano, Alessio Danilo Inchingolo, Francesco Inchingolo, Gianna Dipalma, Ciro Gargiulo Isacco, Elisabetta de Ruvo, Biagio Rapone, Antonio Mancini, Felice Lorusso, Antonio Scarano, Giuseppina Malcangi, Angelo Michele Inchingol. Cannabidiol for Oral Health: A New Promising Therapeutical Tool in Dentistry. International journal of molecular sciences. vol 24. issue 11. 2023-06-11. PMID:37298644. |
although many substances called cannabinoids are present in cannabis, Δ9tetrahydrocannabinol (Δ9-thc), cannabidiol (cbd) and cannabinol (cbn) are the three main cannabinoids that are most present and described. |
2023-06-11 |
2023-08-14 |
Not clear |
| Michael J Kosnett, Ming Ma, Gregory Dooley, George Sam Wang, Kyle Friedman, Timothy Brown, Thomas K Henthorn, Ashley Brooks-Russel. Blood cannabinoid molar metabolite ratios are superior to blood THC as an indicator of recent cannabis smoking. Clinical toxicology (Philadelphia, Pa.). vol 61. issue 5. 2023-06-09. PMID:37293900. |
blood cannabinoid molar metabolite ratios are superior to blood thc as an indicator of recent cannabis smoking. |
2023-06-09 |
2023-08-14 |
Not clear |
| Mariana Pinto Coelho, Patrícia Duarte, Marta Calado, António J Almeida, Catarina Pinto Reis, M Manuela Gaspa. The current role of cannabis and cannabinoids in health: A comprehensive review of their therapeutic potential. Life sciences. 2023-06-08. PMID:37290668. |
the current role of cannabis and cannabinoids in health: a comprehensive review of their therapeutic potential. |
2023-06-08 |
2023-08-14 |
Not clear |
| Mariana Pinto Coelho, Patrícia Duarte, Marta Calado, António J Almeida, Catarina Pinto Reis, M Manuela Gaspa. The current role of cannabis and cannabinoids in health: A comprehensive review of their therapeutic potential. Life sciences. 2023-06-08. PMID:37290668. |
although it is believed that cannabinoids can be effective for a few different conditions and syndromes, there are little objective data that clearly support the use of cannabis, cannabis extracts or even cannabidiol (cbd) oil. |
2023-06-08 |
2023-08-14 |
Not clear |
| Inga Dammann, Claudia Keil, Iris Hardewig, Elżbieta Skrzydlewska, Michał Biernacki, Hajo Haas. Effects of combined cannabidiol (CBD) and hops (Humulus lupulus) terpene extract treatment on RAW 264.7 macrophage viability and inflammatory markers. Natural products and bioprospecting. vol 13. issue 1. 2023-06-07. PMID:37284961. |
this study investigates the potential of cannabidiol (cbd), one major cannabinoid of the plant cannabis sativa, alone and in combination with a terpene-enriched extract from humulus lupulus ("hops 1"), on the lps-response of raw 264.7 macrophages as an established in vitro model of inflammation. |
2023-06-07 |
2023-08-14 |
Not clear |
| Carmen-Adella Sirbu, Ruxandra Georgescu, Florentina Cristina Pleşa, Alina Paunescu, Monica Marilena Ţânţu, Alina Crenguţa Nicolae, Ionut Caloianu, Marian Mitric. Cannabis and Cannabinoids in Multiple Sclerosis: From Experimental Models to Clinical Practice-A Review. American journal of therapeutics. vol 30. issue 3. 2023-06-06. PMID:37278703. |
cannabis and cannabinoids in multiple sclerosis: from experimental models to clinical practice-a review. |
2023-06-06 |
2023-08-14 |
Not clear |
| István Ujvár. Hexahydrocannabinol and closely related semi-synthetic cannabinoids: A comprehensive review. Drug testing and analysis. 2023-06-03. PMID:37269160. |
parallel to legislative changes in some jurisdictions regarding herbal cannabis, unregulated and cheap synthetic cannabinoids with astonishing structural diversity have emerged. |
2023-06-03 |
2023-08-14 |
Not clear |
| István Ujvár. Hexahydrocannabinol and closely related semi-synthetic cannabinoids: A comprehensive review. Drug testing and analysis. 2023-06-03. PMID:37269160. |
by now, hemp-derived cannabidiol (cbd), initially a blockbuster product on its own, became a "precursor" to semi-synthetic cannabinoids such as hexahydrocannabinol (hhc), which appeared on the drug market in 2021. |
2023-06-03 |
2023-08-14 |
Not clear |
| Guanghui Tang, Ying-Jie Lim, Wei Wang, Zi Ye, Chong-Jing Zhang, Shao Q Ya. Orthogonal Strategies for Profiling Potential Cellular Targets of Anandamide and Cannabidiol. Chemistry (Weinheim an der Bergstrasse, Germany). 2023-06-02. PMID:37265377. |
anandamide (aea) and cannabidiol (cbd) are classical examples of cannabinoids that elicit a variety of effects, both beneficial and detrimental, through these receptors. |
2023-06-02 |
2023-08-14 |
human |
| Jordan Kirby, Thileepan Nare. Cannabinoid hyperemesis syndrome in pregnancy: Challenges and opportunities. The Australian & New Zealand journal of obstetrics & gynaecology. 2023-06-01. PMID:37259610. |
cannabinoid hyperemesis syndrome (chs) comprises severe, cyclical episodes of vomiting, intractable nausea and abdominal pain observed in chronic cannabis users. |
2023-06-01 |
2023-08-14 |
Not clear |